Among older men with low testosterone levels, testosterone administration for three years compared with placebo did not result in a significant difference in the rates of change in atherosclerosis, nor was it associated with improved overall sexual function or health-related quality of life, according to a study in the Journal of the American Medical Association.
The National Institute for Health and Care Excellence (NICE), the medicines cost-effectiveness body for England and Wales, has recommended a new treatment to help patients suffering from blood clots in the legs and lungs.
The first patient has been enrolled in ETNA-AF-Europe (Edoxaban treatment in routine clinical practice – atrial fibrillation – Europe), and ETNA-VTE-Europe (Edoxaban treatment in routine clinical practice – venous thromboembolism – Europe) has commenced.
Results of the landmark CATCH (Comparison of Acute Treatments in Cancer Haemostasis) study were published in The Journal of American Medical Association (JAMA), comparing innohep (tinzaparin), a low-molecular weight heparin (LMWH), with warfarin in patients with cancer-associated thrombosis.
Speaking to Interventional News on the SIRFLOX trial results at the Global Embolization Symposium and Technologies (GEST EU, 24–27 June, Seville, Spain) meeting, Ricky Sharma, professor and honorary consultant of Clinical Oncology at the University of Oxford and Oxford University Hospitals Trust said: “We need to know more about patient selection for radioembolization.
It is important to use the right embolic agent for the job – an embolic agent that is particularly suitable for one indication may not at all be appropriate for another. Robert Morgan, vascular interventional radiologist, St Georges Hospital, London, UK, tells Interventional News why he uses liquid embolic agents, such as ethylene vinyl oxide copolymer (EVOH-based) liquid agents, of which Onyx (Medtronic) is an example, for endoleak embolization.
Spectranetics has completed enrolment of 300 patients in the ILLUMENATE pivotal clinical study, a prospective, randomised controlled, multicentre study designed to assess the clinical performance of the Stellarex drug-coated angioplasty balloon used to restore and maintain blood flow to above-the-knee arteries of the leg in patients with peripheral arterial disease (PAD).
This video visually explains the process for transarterial chemoembolization (TACE) using bioresorbable microspheres, a new type of embolic agent that is being tested in various embolization procedures. These bioresorbable embolic beads, from EmboMedics, are made of cellulose and chitosan and offer the potential for controlled and predictable drug release and bead absorption.
The trial’s results were published in JACC: Cardiovascular Interventions and show no intracranial haemorrhage and no death among massive pulmonary embolism patients.
The Society of Interventional Radiology (SIR) is accepting scientific abstracts covering all areas of vascular and nonvascular interventional radiology for its 41st Annual Scientific Meeting, which will be held 2–7 April, 2016, in Vancouver, British Columbia, Canada. Online scientific abstract submission is open until 6 October.
Updating national screening policies could help detect a deadly form of aneurysm in older men; saving lives and resources, according to research presented in the Journal of the American Heart Association.
Boston Scientific has received Food and Drug Administration (FDA) approval for the Innova vascular self-expanding stent system, a treatment option for patients with narrowing or blockages in the superficial femoral artery or proximal popliteal artery. This can cause peripheral artery disease of the lower extremities, leading to painful ulcers, infections, or amputation of the toes or feet. The company has commenced a full commercial launch of the Innova system in the USA.
The editor-in-chief of Annals of Internal Medicine, Christine Laine, and her fellow editors have called for doctors to confront colleagues who act in a disrespectful manner towards patients after an anonymous essay in the journal highlighted incidences in which unprofessional behaviour was condoned. Laine et al claim that doctors owe it to themselves, their profession, and their patients to address inappropriate actions.
GE Healthcares low dose computed tomography lung cancer screening option is the first to be cleared by the US FDA. Early detection with low dose CT can improve prognosis and treatment and reduce mortality rates for patients with a high risk of lung cancer.
The procedures have been performed by Sandeep Bagla, interventional radiologist, using the Magellan Robotic System. Bagla is one of the world leaders in the development of prostate artery embolization and is at the forefront of applying the Magellan Robotic System to this expanding procedure.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos